-
Comparative integromics on FZD7 orthologs: conserved binding sites for PU.1, SP1, CCAAT-box and TCF/LEF/SOX transcription factors within 5'-promoter region of mammalian FZD7 orthologs.
Int J Mol Med. 2007 Mar;19(3):529-33
PMID: 17273804
-
Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo.
Cell Stem Cell. 2008 Mar 6;2(3):274-83
PMID: 18371452
-
Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer.
Nat Genet. 2001 May;28(1):53-7
PMID: 11326276
-
Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells.
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3304-9
PMID: 16492737
-
CD8+ T-cell memory in tumor immunology and immunotherapy.
Immunol Rev. 2006 Jun;211:214-24
PMID: 16824130
-
Long-term, multilineage hematopoiesis occurs in the combined absence of beta-catenin and gamma-catenin.
Blood. 2008 Jan 1;111(1):142-9
PMID: 17906078
-
Two betas or not two betas: regulation of asymmetric division by beta-catenin.
Trends Cell Biol. 2007 Oct;17(10):465-73
PMID: 17919911
-
Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells.
Nat Med. 2008 Feb;14(2):162-9
PMID: 18246080
-
An HMG-box-containing T-cell factor required for thymocyte differentiation.
Nature. 1995 Mar 2;374(6517):70-4
PMID: 7870176
-
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells.
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9571-6
PMID: 15980149
-
Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1.
Science. 1999 Sep 17;285(5435):1923-6
PMID: 10489374
-
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells.
J Clin Invest. 2005 Jun;115(6):1616-26
PMID: 15931392
-
Control of effector CD8+ T cell function by the transcription factor Eomesodermin.
Science. 2003 Nov 7;302(5647):1041-3
PMID: 14605368
-
Arrested differentiation, the self-renewing memory lymphocyte, and vaccination.
Science. 2001 Jul 13;293(5528):248-50
PMID: 11452114
-
Rapid culling of the CD4+ T cell repertoire in the transition from effector to memory.
Immunity. 2008 Apr;28(4):533-45
PMID: 18356084
-
Asymmetric T lymphocyte division in the initiation of adaptive immune responses.
Science. 2007 Mar 23;315(5819):1687-91
PMID: 17332376
-
Homeostatic T cell proliferation: how far can T cells be activated to self-ligands?
J Exp Med. 2000 Aug 21;192(4):F9-F14
PMID: 10952731
-
Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection.
Immunity. 2007 Sep;27(3):393-405
PMID: 17892848
-
Wnt proteins are lipid-modified and can act as stem cell growth factors.
Nature. 2003 May 22;423(6938):448-52
PMID: 12717451
-
Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3.
J Exp Med. 2000 Jul 3;192(1):99-104
PMID: 10880530
-
Adoptive immunotherapy for cancer: building on success.
Nat Rev Immunol. 2006 May;6(5):383-93
PMID: 16622476
-
Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor.
Nat Med. 2004 Jan;10(1):55-63
PMID: 14702635
-
Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells.
J Clin Invest. 2007 Feb;117(2):492-501
PMID: 17273561
-
WNT signalling in the immune system: WNT is spreading its wings.
Nat Rev Immunol. 2008 Aug;8(8):581-93
PMID: 18617885
-
Host-reactive CD8+ memory stem cells in graft-versus-host disease.
Nat Med. 2005 Dec;11(12):1299-305
PMID: 16288282
-
Persistence of memory CD8 T cells in MHC class I-deficient mice.
Science. 1999 Nov 12;286(5443):1377-81
PMID: 10558996
-
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.
J Exp Med. 2003 Aug 18;198(4):569-80
PMID: 12925674
-
Pharmacological inhibitors of glycogen synthase kinase 3.
Trends Pharmacol Sci. 2004 Sep;25(9):471-80
PMID: 15559249
-
Synthetic small molecules that control stem cell fate.
Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7632-7
PMID: 12794184
-
Turnover of naive- and memory-phenotype T cells.
J Exp Med. 1994 Apr 1;179(4):1127-35
PMID: 8145034
-
Nemo is an inducible antagonist of Wingless signaling during Drosophila wing development.
Development. 2004 Jun;131(12):2911-20
PMID: 15169756
-
Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases.
Nat Rev Immunol. 2006 May;6(5):417-23
PMID: 16622477
-
CD8+ T cell efficacy in vaccination and disease.
Nat Med. 2008 Jun;14(6):623-8
PMID: 18535580
-
Cancer regression in patients after transfer of genetically engineered lymphocytes.
Science. 2006 Oct 6;314(5796):126-9
PMID: 16946036
-
Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo.
J Immunol. 2006 Feb 1;176(3):1439-46
PMID: 16424171
-
Critical involvement of Tcf-1 in expansion of thymocytes.
J Immunol. 1998 Oct 15;161(8):3984-91
PMID: 9780167
-
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy.
Blood. 2008 Jun 1;111(11):5326-33
PMID: 18276844
-
Lineage relationship and protective immunity of memory CD8 T cell subsets.
Nat Immunol. 2003 Mar;4(3):225-34
PMID: 12563257
-
Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas.
Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1603-8
PMID: 9990071
-
Central memory and effector memory T cell subsets: function, generation, and maintenance.
Annu Rev Immunol. 2004;22:745-63
PMID: 15032595